Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 7, 2026 · 10-Q · 37 days after period end · 0001437749-26-015664
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$10.33M | -$23.40M | $25.04M | -$24.27M |
| EPS Diluted | — | -$0.48 | -$0.43 | -$0.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 7, 2026 · 37 d after period end
